Danny Hsu: Rethinking Bleeding Risk in Patients on Anticoagulation
Danny Hsu, President of THANZ, Director of Therapeutic Apheresis, Immune and Obstetric Haematology at South Western Sydney Local Health District, shared Deborah Siegal‘s post on LinkedIn, adding:
“Excellent study by Deborah Siegal et al regarding the incidence and predictors of extracranial bleeding on OAC in AF patients!!!”
Deborah Siegal, Associate Professor, Department of Medicine at University of Ottawa, shared a post on LinkedIn about a recent article she and her colleagues co-authored, published in Circulation journal, adding:
“Newly published in Circulation
Bleeding remains the major complication of oral anticoagulation, but are we focusing on the right bleeding outcome?
In this Combine – AF individual patient meta-analysis of 73,737 patients, we found:
- 1 in 4 patients experienced clinically relevant extracranial bleeding over approximately 2 years.
- Clinically relevant non-major bleeding accounted for the majority of bleeding events.
- Low hemoglobin, impaired kidney function, prior stroke, cancer and Asian ancestry were among the strongest predictors.
- Known risk factors explained only approximately 2/3 of bleeding risk, far less than for stroke or MI, underscoring the need for novel predictors.
The next step: understanding what these bleeds actually mean for patients!
Huge thanks to collaborators Marc Carrier, M Cecilia Bahit, Alexander Benz, Jackie Bosch, Brian Bergmark, Bob Giugliano, Chris Granger, Victorien Monguillon, Martin O’Donnell, Manesh Patel, Jonas Oldgren, Rohin Reddy, Lars Wallentin, Qilong Yi, André Zimerman, John Eikelboom.”
Title: Incidence and Predictors of Extracranial Bleeding on Oral Anticoagulants for Stroke Prevention in Patients With Atrial Fibrillation: A Combine-AF Analysis
Authors: Deborah M. Siegal, Marc Carrier, M. Cecilia Bahit, Jackie Bosch, Alexander P. Benz, Brian Bergmark, Robert P. Giugliano, Christopher B. Granger, Victorien Monguillon, Martin O’Donnell, Jonas Oldgren, Manesh R. Patel, Rohin K. Reddy, Lars Wallentin, Qilong Yi, Andre Zimerman, John Eikelboom
Other posts featuring Danny Hsu and Deborah Siegal on Hemostasis Today.
-
Aug 24, 2026, 17:11Kristin Neves: Which Hematologic Parameters Guide Your PV Treatment Decisions?
-
Aug 24, 2026, 17:00Should Hormone Therapy Automatically Stop After a Thrombosis? – Thrombosis Canada
-
Aug 24, 2026, 16:52Davide Capodanno: 10 Trials to Watch at the ESC Hot Lines
-
Aug 24, 2026, 16:48Mohd Ashhad: The Science Behind a Safe Transfusion
-
Aug 24, 2026, 16:38PCSK9i Is a Powerful Lipid-Lowering Strategy – But Is It Also Anti-Inflammatory?- JACC Journals
-
Aug 24, 2026, 16:36Alejandro González Veliz։ Does ACC/AHA Lesion Complexity Still Matter?
-
Aug 24, 2026, 16:21Kamlesh Darji: Paraneoplastic Syndromes – Tumor with or without Mediator
-
Aug 24, 2026, 15:15Jim Hoffman: Could Targeting NETosis Reduce Long-Term Risk After STEMI?
-
Aug 24, 2026, 14:18The Way to a Safer Workplace for People With Bleeding Disorders – EHC